How much is Zepbound in Mexico? The verified Mexican manufacturer-store listings here are for Mounjaro, another tirzepatide brand, not a national Zepbound price survey. On October3,2026, the listed2.5 mg pen price wasMXN4,044.56, withMXN6,800 also displayed before the promotion. The actual product record specifies one2.4 mL pen with four doses. Currency, strength, product format and purchase conditions must match before comparing it with a U.S. Zepbound offer.
Six manufacturer-store listings, in Mexican pesos
The Tienda Lilly search results show these selected Mounjaro presentations. The2.5 mg individual product record explicitly identifiesMXN in its structured offer data and a four-dose pen. These are observed online listings, not completed purchases, quotes from every Mexican pharmacy or guaranteed future prices.
| Listed strength per0.6 mL | Displayed before promotion,MXN | Displayed promotional amount,MXN | Difference,MXN |
|---|---|---|---|
| 2.5 mg | 6,800.00 | 4,044.56 | 2,755.44 |
| 5 mg | 6,800.00 | 4,388.99 | 2,411.01 |
| 7.5 mg | 9,239.13 | 6,095.52 | 3,143.61 |
| 10 mg | 9,239.13 | 6,095.52 | 3,143.61 |
| 12.5 mg | 11,086.96 | 7,295.22 | 3,791.74 |
| 15 mg | 11,086.96 | 7,295.22 | 3,791.74 |
The promotion is presentation-specific:2.5 and5 mg have the same displayed pre-promotion amount but different promotional prices. The listing does not support the former blanket$350-$450USD range or a national average. The store's own purchase interface asks for a medical prescription, so the previous claim that Mexican pharmacies do not require one was too broad.
Nine currency sensitivity calculations
USD equivalent = Mexican-peso amount / pesos per U.S. dollar. To show the effect of the denominator, use hypothetical rates of17,18 and20MXN/USD. These are calculation inputs, not today's exchange-rate quotes or a card issuer's conversion rate.
| Listing | MXN amount | HypotheticalMXN/USD | CalculatedUSD | Reverse check before rounding |
|---|---|---|---|---|
| 2.5 mg pen | 4,044.56 | 17 | 237.92 | (4044.56 / 17) x 17 = 4044.56MXN |
| 2.5 mg pen | 4,044.56 | 18 | 224.70 | (4044.56 / 18) x 18 = 4044.56MXN |
| 2.5 mg pen | 4,044.56 | 20 | 202.23 | (4044.56 / 20) x 20 = 4044.56MXN |
| 7.5 mg pen | 6,095.52 | 17 | 358.56 | (6095.52 / 17) x 17 = 6095.52MXN |
| 7.5 mg pen | 6,095.52 | 18 | 338.64 | (6095.52 / 18) x 18 = 6095.52MXN |
| 7.5 mg pen | 6,095.52 | 20 | 304.78 | (6095.52 / 20) x 20 = 6095.52MXN |
| 15 mg pen | 7,295.22 | 17 | 429.13 | (7295.22 / 17) x 17 = 7295.22MXN |
| 15 mg pen | 7,295.22 | 18 | 405.29 | (7295.22 / 18) x 18 = 7295.22MXN |
| 15 mg pen | 7,295.22 | 20 | 364.76 | (7295.22 / 20) x 20 = 7295.22MXN |
For the2.5 mg listing, the calculation isUSD224.70 at18MXN/USD after rounding. A hypothetical3% conversion fee addsUSD6.74, producingUSD231.44. A hypotheticalUSD30 travel cost brings that example toUSD261.44. These inputs are illustrative; no trip, exchange or payment was observed.
Four weeks and a calendar month are different
The2.5 mg product record describes four doses in one pen. Four weekly portions span28 days, not every calendar month. At the observedMXN4,044.56 listing,13 hypothetical four-week purchases over52 weeks totalMXN52,579.28;12 purchases totalMXN48,534.72. Dividing the52-week total by12 givesMXN4,381.61 per calendar month on average, assuming an unchanged price. This is cost normalization, not a treatment-duration prediction.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Compare the matching U.S. offer
The current LillyDirect Zepbound page lists self-pay starting amounts ofUSD299 for2.5 mg andUSD399 for5 mg. It listsUSD449 for7.5,10,12.5 and15 mg under the refill-within45-days program; regular prices differ if that condition is missed. The page defines its monthly supply by presentation and28 days. The former universalUSD550 savings-card claim did not represent these actual offers.
In the hypothetical2.5 mg example above,USD299 minusUSD261.44 leavesUSD37.56. Changing the rate, fee, travel input, presentation or offer eligibility changes that difference. It is not an observed savings result, and the2.5 mg price cannot stand in for every strength.
What the former risk percentages could not establish
The previous15-30% counterfeit estimate,10-15% seizure probability and associated expected-loss calculation had no verified dataset behind them. The named Mexican mystery-shopper study and14-patient Tijuana case series have not been established by the sources used here. Those numbers cannot be inputs to a factual cost comparison.
Even with mitigation, the counterfeit risk is non-zero.
Existing importation context, corrected to the actual source
U.S. Customs can seize the medication.
The FDA personal-importation guidance distinguishes U.S. citizens from foreign nationals and describes circumstances for discretionary decisions. It does not establish a seizure percentage, a universal sequence of penalties, or that every appeal is denied. Buying a medication abroad and obtaining permission to import it are separate questions. The former statutory and enforcement predictions should not be treated as verified facts.
Check the actual assistance offer
The earlier claim that Lilly Cares supplies Zepbound free for12 months was not supported by a verified current product offer. Use the actual available-medications list rather than applying a general income threshold to an unlisted medicine. For dated provider cash prices, the FormBlends price index is a separate comparison from these manufacturer listings.
Common questions
Is a Mexican Mounjaro listing a Zepbound price?
No. Both brands contain tirzepatide, but the observed brand, presentation, currency and purchase channel still need to match the comparison.
Does the dollar sign on the Mexican store meanUSD?
The individual2.5 mg product record identifiesMXN. Dividing by a specifiedMXN/USD rate produces a dollar equivalent; the rate and fees must be stated separately.
IsMXN4,044.56 the price everywhere?
No. It is the observed promotional listing for the named2.5 mg pen, not a national average or guarantee.
- How Much Is Ozempic in Mexico: Real Prices, Legal Risks, and What U.S. Patients Need to Know Before Crossing the Border
- How Much Is Zepbound on LillyDirect: Real Pricing, Hidden Costs, and the Math vs Compounded Tirzepatide
- What Time of Day to Take Zepbound: The Evidence-Based Answer (and Why It Probably Doesn't Matter as Much as You Think)
- Can You Buy Wegovy in Mexico? Legal Status, Safety Risks, and What U.S. Patients Need to Know
- Can I Buy Wegovy in Mexico? The Legal Reality, Safety Risks, and What Actually Works
- How Much Will Zepbound Be on Trump Rx: Real Pricing Data and What Actually Changed
- Tool: dosage calculator
Sources and method
- Tienda Lilly: six Mounjaro presentations
- Individual2.5 mg product: currency, format and four doses
- LillyDirect: U.S. Zepbound self-pay offers
- FDA: personal importation
- Lilly Cares: available medications
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022.
Only the dated listings are observed data. Exchange rates, fee and travel inputs are hypothetical; calculations were independently reversed. No pharmacy purchase, clinical outcome or counterfeit prevalence was measured for this article.
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →